October 13, 2011
In the first-half (March-August) business results for 2011 of Hisamitsu Pharmaceutical, sales of Norspan Tape (buprenorphine), a long-acting transdermal patch for the treatment of chronic pain launched in August, was ¥44 million, fallen short of the initial forecast of ￥100...read more